LGND logo
LGND

LIGAND PHARMACEUTICALS INC

LIGAND PHARMACEUTICALS INC (LGND) SEC Filings

8 recent LGND filings from SEC EDGAR — annual (10-K) and quarterly (10-Q) reports, 8-K disclosures, and insider Form 4s.

TypeFiledDescriptionLink
4Sep 8, 20264 - Reardon Andrew (0001950232) (Reporting)View Doc ↗
4Jun 9, 20264 - Zimmermann Martine (0001994049) (Reporting)View Doc ↗
4Jun 9, 20264 - Sabba Stephen L (0001442372) (Reporting)View Doc ↗
4Jun 9, 20264 - LAMATTINA JOHN L (0001216074) (Reporting)View Doc ↗
4Jun 9, 20264 - Haas Jason (0001883821) (Reporting)View Doc ↗
4Jun 9, 20264 - Gray Nancy Ryan (0001714949) (Reporting)View Doc ↗
4Jun 9, 20264 - KOZARICH JOHN W (0001223000) (Reporting)View Doc ↗
4May 28, 20264 - Espinoza Octavio (0001905248) (Reporting)View Doc ↗

Showing 5 of 8 LGND filings

Including the latest 4 filed Sep 8, 2026.

Sign up free to see all 8 + get insider-buy alerts.

Sign up free →